We are cancer researchers Adam Marcus, PhD, and Suresh Ramalingam, MD, ask us anything about cancer and the future of personalized cancer medicine!
Hi everyone! We are Adam Marcus, PhD, a cancer scientist, and Suresh Ramalingam, MD , a medical oncologist specializing in lung cancer, from the Winship Cancer Institute of Emory University. In honor of National Cancer Research Month, we are here to answer any and all questions that you have about cancer research in the area of personalized medicine.
-Adam Marcus is an Associate Professor in the Dept. of Hematology and Oncology, a former Georgia Cancer Coalition Scholar, and directs a federally funded cancer research laboratory. His research focuses on understanding how cancer cells become malignant with the goal of developing new treatments that could help stop the spread of cancer. He also runs a science education community outreach program that brings microscopes into classrooms across Georgia.
-You can find him on Twitter @NotMadScientist & his blog writing about personalized medicine at www.notamadscientist.com
-Suresh Ramalingam: As Chief of Thoracic Oncology at Winship Cancer Institute, I lead a multi-disciplinary team for the treatment of lung cancer in patients and I am a well-known specialist. My research focus has been to develop new drugs for the treatment of lung cancer. I also have a strong interest in the conduct of early phase clinical trials with novel translational endpoints to identify molecular effects of the experimental agents at the tumor level.
-You can find him on Twitter at @RamalingamMD
-You can also follow Winship on Twitter at @WinshipAtEmory
We are just about finished. Thanks for all the great questions!